reports
- Dave Nicoski
- Ross LaDuke
UFI UNIFI INC
PAG PENSKE AUTOMOTIVE GROUP INC
URI UNITED RENTALS INC.
STT STATE STREET CORPORATION
SWK STANLEY BLACK & DECKER INC.
HZO MARINEMAX INC.
ZION ZIONS BANCORPORATION N.A.
WAL WESTERN ALLIANCE BANCORP
URBN URBAN OUTFITTERS INC.
THC TENET HEALTHCARE CORPORATION
TBI TRUEBLUE INC.
RUSHA RUSH ENTERPRISES INC. CLASS A
RM REGIONAL MANAGEMENT CORP
RF REGIONS FINANCIAL CORPORATION
PPBI PACIFIC PREMIER BANCORP INC.
PNFP PINNACLE FINANCIAL PARTNERS INC.
PENN PENN NATIONAL GAMING INC.
PCH POTLATCHDELTIC CORPORATION
PBF PBF ENERGY INC. CLASS A
MNTA MOMENTA PHARMACEUTICALS INC.
DLY LYONDELLBASELL INDUSTRIES NV
LVS LAS VEGAS SANDS CORP.
LBAI LAKELAND BANCORP INC.
JWN NORDSTROM INC.
JBLU JETBLUE AIRWAYS CORPORATION
HAIN HAIN CELESTIAL GROUP INC.
GWB GREAT WESTERN BANCORP INC.
GT GOODYEAR TIRE & RUBBER COMPANY
FSB FRANKLIN FINANCIAL NETWORK INC
FITB FIFTH THIRD BANCORP
FIBK FIRST INTERSTATE BANCSYSTEM INC. CLASS A
FHN FIRST HORIZON CORPORATION
FCF FIRST COMMONWEALTH FINANCIAL CORPORATION
ETN EATON CORP. PLC
EMN EASTMAN CHEMICAL COMPANY
EFSC ENTERPRISE FINANCIAL SERVICES CORP
EBS EMERGENT BIOSOLUTIONS INC.
EAT BRINKER INTERNATIONAL INC.
CUBI CUSTOMERS BANCORP INC.
CENTERSTATE BANK CORPORATION
COLB COLUMBIA BANKING SYSTEM INC.
CMC COMMERCIAL METALS COMPANY
BRKL BROOKLINE BANCORP INC.
AXE ANIXTER INTERNATIONAL INC.
ALNY ALNYLAM PHARMACEUTICALS INC
AEIS ADVANCED ENERGY INDUSTRIES INC.
GNK GENCO SHIPPING & TRADING LTD.
TK TEEKAY CORPORATION
CAT CATERPILLAR INC.
BJRI BJ'S RESTAURANTS INC.
FNB F.N.B. CORPORATION
TILE INTERFACE INC.
MCK MCKESSON CORPORATION
ACLS AXCELIS TECHNOLOGIES INC.
CAH CARDINAL HEALTH INC.
CBPX CONTINENTAL BUILDING PRODUCTS INC.
COHU COHU INC.
EV EATON VANCE CORP.
GEF GREIF CLASS A
HNI HNI CORPORATION
MINI MOBILE MINI INC.
THO THOR INDUSTRIES INC.
TSC TRISTATE CAPITAL HOLDINGS INC
VSH VISHAY INTERTECHNOLOGY INC.
CHRW C.H. ROBINSON WORLDWIDE INC.
SYX SYSTEMAX INC.
5AH PANHANDLE OIL & GAS INC.
JHG JANUS HENDERSON GROUP PLC
MATW MATTHEWS INTERNATIONAL CORPORATION CLASS A
CBMG CELLULAR BIOMEDICINE GROUP INC
DLX DELUXE CORPORATION
ABBV ABBVIE INC.
HOG HARLEY-DAVIDSON INC.
DOW DOW INC.
Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp...
Cellular Biomedicine Group Appoints CAR-T Pioneer Dr. Stephan A. Grupp as Member of Scientific Advisory Board SHANGHAI, China and NEW YORK, Dec. 18, 2018 (GLOBE NEWSWIRE) -- . (NASDAQ: CBMG) (“CBMG” or the “Company”), a biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced the appointment of Dr. Stephan A. Grupp, a CAR-T pioneer and pediatric oncologist, to CBMG’s Scientific Advisory Board to impart scientific vigor and clinical guidance in the Company’s immuno-oncology pipeline. “Dr. Grupp is ...
Cellular Biomedicine Group Reports Third Quarter Financial Results and...
Cellular Biomedicine Group Reports Third Quarter Financial Results and Recent Business Highlights Debuted its next 12-18 months’ immuno-oncology clinical development programs for both hematologic malignancies and solid tumors to key opinion leaders, investment and industry executivesLicensed patents from the National Cancer Institute (“NCI”) to develop the next generation neoantigen-reactive tumor infiltrating lymphocyte (“TIL”) technology to treat a variety of cancersStruck a strategic licensing and collaboration agreement with Novartis to manufacture and supply the CAR-T cell therapy Kymr...
Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pip...
Cellular Biomedicine Group to Provide Company Cancer Immunotherapy Pipeline Update and Facility Tour for Attendees of the Advanced Cell Therapy Summit in Shanghai SHANGHAI, China and CUPERTINO, Calif., Oct. 25, 2018 (GLOBE NEWSWIRE) -- . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, will provide a Company cancer immunotherapy pipeline update and host a tour of its GMP facility for attendees of the Advanced Cell Therapy Summit 2018 in Shanghai on M...
- Dr Nathaniel Calloway
Cellular Biomedicine Group - CBMG and Novartis sign manufacturing part...
Cellular Biomedicine Group (CBMG) announced it has signed an exclusive partnership with Novartis to manufacture the CAR-T therapy Kymriah in China. Novartis retains all marketing responsibility and CBMG will be entitled to both a mark-up on manufacturing costs and an escalating single-digit royalty on sales. Additionally, Novartis will take an equity stake in CBMG of approximately 9%: $40m at $27.43/share. Our valuation is lifted to $535m (from $353.1m).
Cellular Biomedicine Group Obtained NCI Patent License for Next Genera...
Cellular Biomedicine Group Obtained NCI Patent License for Next Generation Neoantigen-Reactive Tumor Infiltrating Lymphocyte (TIL) Technology to Treat Solid Tumors SHANGHAI, China and CUPERTINO, Calif., Oct. 03, 2018 (GLOBE NEWSWIRE) -- . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced it has entered into a Patent License Agreement (the “License Agreement”) with the National Cancer Institute (“NCI”), an institute of the National Ins...
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Gl...
Cellular Biomedicine Group to Present at the Cantor Fitzgerald 2018 Global Healthcare Conference SHANGHAI, China and CUPERTINO, Calif., Sept. 24, 2018 (GLOBE NEWSWIRE) -- . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that management will present a Company update and host investor meetings at the Cantor Fitzgerald 2018 Global Healthcare Conference. Date: October 2, 2018 at 10:20AM Eastern Time Location: InterContinental New Yo...
Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR ...
Cellular Biomedicine Group to Present on Three Panels at B. Riley FBR Annual Healthcare Conference SHANGHAI, China and CUPERTINO, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- . (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced that the Company will present on three panels at the B. Riley FBR Annual Healthcare Conference to be held on September 4, 2018 in New York City, as well as meeting with investors. The panels will range in topics fr...
Cellular Biomedicine Group Announces Grand Opening of Global Research ...
Cellular Biomedicine Group Announces Grand Opening of Global Research and Development Center in Gaithersburg, Maryland SHANGHAI, China and CUPERTINO, Calif., June 22, 2018 (GLOBE NEWSWIRE) -- . (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, today announced the grand opening of a new research and development center in Gaithersburg, Maryland. “We are elated to announce the opening of a research center located in the heart of a renowned cancer cell th...
Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Sum...
Cellular Biomedicine Group to Present a Keynote Address at CAR-TCR Summit Asia SHANGHAI, China and CUPERTINO, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- . (NASDAQ:CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancer and stem cell therapies for degenerative diseases, will participate in the upcoming CAR-TCR Summit Asia to be held in Singapore, June 27-28, 2018. The Company’s CEO, Tony (Bizuo) Liu, will present a keynote address entitled “Digital Decades Ahead For Biotech” as part of the “Manufacturing Scale Up & Au...
- Dr Nathaniel Calloway
Cellular Biomedicine Group - Results from AlloJoin Phase I
In March 2018, Cellular Biomedicine Group (CBMG) announced results from the Phase I study of AlloJoin for knee osteoarthritis (KOA). The primary endpoint was safety, and the adverse event (AE) profile was similar to previous studies, with pain and swelling as the primary effects. The company did not release detailed efficacy data, but it appears that the treatment effect was sustained for 48 weeks, and it appeared to stop cartilage degradation.
- Jonathan Moreland
VECO VEECO INSTRUMENTS INC.
SRN SPRINT CORP.
ROX CASTLE BRANDS
EVEREST RE GROUP LTD.
PSMT PRICESMART INC.
PRCP PERCEPTRON INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MOFG MIDWESTONE FINANCIAL GROUP
A2N6GQ LEGACY RESERVES
WXC1 CENTERSPACE
HSTM HEALTHSTREAM INC.
GABC GERMAN AMERICAN BANCORP
FTAI FORTRESS TRANSPORTATION AND INFRASTRUCTURE INVESTORS LLC
FSIC FS KKR CAPITAL CORP.
DYNT DYNATRONICS
CPSS CONSUMER PORTFOLIO SERVICES INC.
CORI CORIUM INTERNATIONAL
CHTR CHARTER COMMUNICATIONS INC. CLASS A
BOCH BANK OF COMMERCE HOLDINGS
ASPS ALTISOURCE PORTFOLIO SOLUTIONS S.A.
ALIM ALIMERA SCIENCES
AKAO ACHAOGEN INC.
MCBC MACATAWA BANK CORP.
SKY SKYLINE CHAMPION CORPORATION
SHLD SEARS HOLDINGS CORPORATION
ANY SPHERE 3D CORP
CCV COUNTERPATH
CQP CHENIERE ENERGY PARTNERS L.P.
OW0A OCWEN FINANCIAL CORPORATION
VSI VITAMIN SHOPPE
PCF PUTNAM HIGH INCOME SECURITIES FUND
NYNY EMPIRE RESORTS INC.
SYRS SYROS PHARMACEUTICALS
CNBKA CENTURY BANCORP INC. CL A
RETA REATA PHARMACEUTICALS INC. CLASS A
SBAC SBA COMMUNICATIONS CORP. CLASS A
APEN APOLLO ENDOSURGERY
AAXN AXON ENTERPRISE
JILL INC.
WOW J.JILL INC.
KALA WIDEOPENWEST INC.
CBMG KALA PHARMACEUTICALS INC.
TEI CELLULAR BIOMEDICINE GROUP INC
MSF TEMPLETON EMERGING MARKETS INCOME FUND
STKL MORGAN STANLEY EMERGING MARKETS FUND INC.
COGT SUNOPTA
JOE INC.
UNTY FLUENT INC
MFOND ST JOE CO.
CHN UNITY BANCORP INC.
ARGS MOBIVITY HOLDINGS
THE CHINA FUND
INC.
ARGOS THERAPEUTICS INC
- Jonathan Moreland
BASX BASIC ENERGY SERVICES INC.
SHAK SHAKE SHACK INC. CLASS A
VECO VEECO INSTRUMENTS INC.
UAN CVR PARTNERS LP
SRN SPRINT CORP.
ROX CASTLE BRANDS
EVEREST RE GROUP LTD.
PSMT PRICESMART INC.
PRGX PRGX GLOBAL
PRCP PERCEPTRON INC.
PLAY DAVE & BUSTER'S ENTERTAINMENT INC.
OPK OPKO HEALTH INC.
NMFC NEW MOUNTAIN FINANCE CORPORATION
MNOV MEDICINOVA
MELI MERCADOLIBRE INC.
A2N6GQ LEGACY RESERVES
WXC1 CENTERSPACE
HSTM HEALTHSTREAM INC.
GPRO GOPRO INC. CLASS A
GABC GERMAN AMERICAN BANCORP
FTAI FORTRESS TRANSPORTATION AND INFRASTRUCTURE INVESTORS LLC
FSIC FS KKR CAPITAL CORP.
DYNT DYNATRONICS
DISCA DISCOVERY INC. CLASS A
CORI CORIUM INTERNATIONAL
CHTR CHARTER COMMUNICATIONS INC. CLASS A
BKMU BANK MUTUAL CORP.
ASPS ALTISOURCE PORTFOLIO SOLUTIONS S.A.
ASB ASSOCIATED BANC-CORP
AKAO ACHAOGEN INC.
MCBC MACATAWA BANK CORP.
SKY SKYLINE CHAMPION CORPORATION
CCV COUNTERPATH
CQP CHENIERE ENERGY PARTNERS L.P.
FI FRANK'S INTERNATIONAL NV
OW0A OCWEN FINANCIAL CORPORATION
VSI VITAMIN SHOPPE
PCF PUTNAM HIGH INCOME SECURITIES FUND
NYNY EMPIRE RESORTS INC.
SYRS SYROS PHARMACEUTICALS
CNBKA CENTURY BANCORP INC. CL A
RETA REATA PHARMACEUTICALS INC. CLASS A
SBAC SBA COMMUNICATIONS CORP. CLASS A
APEN APOLLO ENDOSURGERY
AAXN AXON ENTERPRISE
JILL INC.
WOW J.JILL INC.
KALA WIDEOPENWEST INC.
CBMG KALA PHARMACEUTICALS INC.
TEI CELLULAR BIOMEDICINE GROUP INC
MSF TEMPLETON EMERGING MARKETS INCOME FUND
STKL MORGAN STANLEY EMERGING MARKETS FUND INC.
COGT SUNOPTA
JOE INC.
FLUENT INC
ST JOE CO.
- Dr Nathaniel Calloway
- Cell therapy for China and the US
We are initiating coverage on Cellular Biomedicine Group (CBMG), a trans-Pacific cell therapy company developing products in China and the US. It has two ongoing Phase I clinical trials of CD19 chimeric antigen receptor T-cell (CAR-T) therapies for blood cancers in China. Additionally, it is adapting its knee osteoarthritis (KOA) treatment ReJoin as an allogeneic product, AlloJoin, which it hopes to develop in the US after a 2017 or 2018 IND. We arrive at an initial valuation of $191.6m or $13.5...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.